Yellow Dye 5 vs Butylated Hydroxyanisole: which is worse?

What is Yellow Dye 5?

Yellow Dye 5 (tartrazine) is a synthetic lemon-yellow azo dye derived from petroleum. It produces a bright, stable yellow color in acidic conditions and is one of the most widely used yellow dyes globally. Its chemical formula is C16H9N4Na3O9S2.

What is Butylated Hydroxyanisole?

Butylated hydroxyanisole (BHA) is a synthetic phenolic antioxidant preservative derived from petroleum. It is a mixture of two isomeric compounds (2-BHA and 3-BHA). BHA prevents fats and oils from oxidizing (going rancid), extending shelf life. Its chemical formula is C11H16O2.

Documented risks

Yellow Dye 5: Yellow Dye 5 was one of six dyes studied in the landmark 2007 McCann et al. study in The Lancet. The study found statistically significant increases in hyperactivity in children ages 3 and 8–9 given a mixture containing tartrazine and sodium benzoate. EFSA reviewed the evidence and confirmed the effect was real, mandating the EU warning label from 2010. A 2012 review in Neurotherapeutics (Arnold et al.) confirmed that artificial food colors including tartrazine have a small but statistically significant adverse effect on children's behavior that is not confined to those with diagnosed ADHD. Tartrazine is one of the most documented causes of food dye hypersensitivity. Cross-reactivity with aspirin (acetylsalicylic acid, ASA) is well established in allergy literature: individuals with aspirin hypersensitivity have elevated risk of reacting to tartrazine. Symptoms include urticaria, angioedema, rhinitis, and in rare cases anaphylaxis. Prevalence of tartrazine sensitivity is estimated at 0.1% of the population but higher in aspirin-sensitive individuals. Because of this known hypersensitivity risk, the FDA specifically requires Yellow No. 5 to be declared by name on US food labels — an exceptional requirement not applied to most other additives, reflecting the FDA's acknowledgment of this real clinical concern. EFSA's 2009 re-evaluation found no evidence of genotoxicity in standard test systems at food use levels, setting an ADI of 7.5 mg/kg body weight, but noted in vitro evidence at higher doses. In April 2025, the FDA announced plans to phase out Yellow 5 along with other petroleum-based dyes.

Butylated Hydroxyanisole: BHA is classified by the International Agency for Research on Cancer (IARC) as Group 2B (possible human carcinogen) based on studies showing it causes papillomas and squamous cell carcinomas of the forestomach in rats, hamsters, and mice at high doses. A 1983 NTP bioassay confirmed these findings. The National Toxicology Program lists BHA as 'reasonably anticipated to be a human carcinogen' in its Report on Carcinogens. The forestomach is an anatomical structure found in rodents but not humans, creating some uncertainty about direct extrapolation. EFSA's 2012 re-evaluation (EFSA Journal 2012;10(10):2588) concluded that BHA may have endocrine-disrupting potential based on animal data showing interactions with estrogen receptors and androgenic hormone pathways. EFSA found the ADI of 1 mg/kg body weight but noted concerns about endocrine effects. Japan banned BHA for use in foods containing fats and oils, consistent with its generally precautionary approach to synthetic food preservatives. In cosmetics, the EU Scientific Committee on Consumer Safety (SCCS) has assessed BHA and found potential endocrine-disrupting effects at dermal exposure levels. EWG rates BHA as high-concern in Skin Deep cosmetics database. The antioxidant paradox applies: while BHA prevents lipid oxidation in foods, it may paradoxically act as a pro-oxidant in certain biological contexts at certain doses.